VALN
Valneva SE ADR
NASDAQ: VALN · HEALTHCARE · BIOTECHNOLOGY
$5.38
+0.94% today
Updated 2026-04-30
Market cap
$480.43M
P/E ratio
—
P/S ratio
2.75x
EPS (TTM)
$-1.59
Dividend yield
—
52W range
$5 – $12
Volume
0.1M
Valneva SE ADR (VALN) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |